Ahmad Saeed Khalil

Ahmad Saeed Khalil

Auto-generated profile, based on publicly available information

Ahmad Saeed Khalil

Biological Design Center, Boston University, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
BWBrandon G Wong
Brandon G Wong
CMChristopher P Mancuso
Christopher P Mancuso
SKSzilvia Kiriakov
Szilvia Kiriakov
CBCaleb J Bashor
Caleb J Bashor
AKAhmad S Khalil
Ahmad S Khalil

8 April 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
HLHenry H. Lee
Henry H. Lee
NONili Ostrov
Nili Ostrov
BWBrandon G. Wong
Brandon G. Wong
MGMichaela A. Gold
Michaela A. Gold
AKAhmad S. Khalil
Ahmad S. Khalil
GCGeorge Church
George Church

14 April 2022 in Cell
Verified
Journal Article
Closed access
IZIowis Zhu
Iowis Zhu
RLRaymond Liu
Raymond Liu
JGJulie M. Garcia
Julie M. Garcia
AHAxel Hyrenius-Wittsten
Axel Hyrenius-Wittsten
DPDan I. Piraner
Dan I. Piraner
KRKole T. Roybal
Kole T. Roybal

16 December 2022 in Science
Verified
Journal Article
Closed access
HLHui-Shan Li
Hui-Shan Li
DIDivya V. Israni
Divya V. Israni
KGKeith A. Gagnon
Keith A. Gagnon
KGKok Ann Gan
Kok Ann Gan
MRMichael H. Raymond
Michael H. Raymond
AKAhmad S. Khalil
Ahmad S. Khalil
Synthetic gene circuits that precisely control human cell function could expand the capabilities of gene- and cell-based therapies. However, platforms for developing circuits in primary human cells that drive robust functional changes in vivo and have compositions suitable for clinical use are lacking. Here, we developed synthetic zinc finger transcription regulators (synZiFTRs), which are compact and based largely on human-derived proteins. As a proof of principle, we engineered gene switches and circuits that allow precise, user-defined control over therapeutically relevant genes in primary T cells using orthogonal, US Food and Drug Administration–approved small-molecule inducers. Our circuits can instruct T cells to sequentially activate multiple cellular programs such as proliferation and antitumor activity to drive synergistic therapeutic responses. This platform should accelerate the development and clinical translation of synthetic gene circuits in diverse human cell types and contexts.

2 February 2018 in eLife
Verified
Journal Article
Open access
JKJoanna Krakowiak
Joanna Krakowiak
XZXu Zheng
Xu Zheng
NPNikit Patel
Nikit Patel
ZFZoë A Feder
Zoë A Feder
JAJayamani Anandhakumar
Jayamani Anandhakumar
DPDavid Pincus
David Pincus
Models for regulation of the eukaryotic heat shock response typically invoke a negative feedback loop consisting of the transcriptional activator Hsf1 and a molecular chaperone. Previously we identified Hsp70 as the chaperone responsible for Hsf1 repression and constructed a mathematical model that recapitulated the yeast heat shock response (Zheng et al., 2016). The model was based on two assumptions: dissociation of Hsp70 activates Hsf1, and transcriptional induction of Hsp70 deactivates Hsf1. Here we validate these assumptions. First, we severed the feedback loop by uncoupling Hsp70 expression from Hsf1 regulation. As predicted by the model, Hsf1 was unable to efficiently deactivate in the absence of Hsp70 transcriptional induction. Next, we mapped a discrete Hsp70 binding site on Hsf1 to a C-terminal segment known as conserved element 2 (CE2). In vitro, CE2 binds to Hsp70 with low affinity (9 µM), in agreement with model requirements. In cells, removal of CE2 resulted in increased basal Hsf1 activity and delayed deactivation during heat shock, while tandem repeats of CE2 sped up Hsf1 deactivation. Finally, we uncovered a role for the N-terminal domain of Hsf1 in negatively regulating DNA binding. These results reveal the quantitative control mechanisms underlying the heat shock response.

19 May 2022 in Nature Reviews Methods Primers
Verified
Journal Article
Open access
PDF file
RMRosana S. Molina
Rosana S. Molina
GRGordon Rix
Gordon Rix
AMAmanuella A. Mengiste
Amanuella A. Mengiste
BÁBeatriz Álvarez
Beatriz Álvarez
DSDaeje Seo
Daeje Seo
CLChang C. Liu
Chang C. Liu
Directed evolution has revolutionized biomolecular engineering by applying cycles of mutation, amplification and selection to genes of interest (GOIs). However, classical directed evolution methods that rely on manually staged evolutionary cycles constrain the scale and depth of the evolutionary search that is possible. We describe genetic systems that achieve cycles of rapid mutation, amplification and selection fully inside living cells, enabling the continuous evolution of GOIs as cells grow. These systems advance the scale, evolutionary search depth, ease and overall power of directed evolution and access important new areas of protein evolution and engineering.